Drug Side Effects
Search
POORLY DIFFERENTIATED THYROID CARCINOMA
POORLY DIFFERENTIATED THYROID CARCINOMA
was reported 10 times
These drug classes are most commonly taken by patients reporting POORLY DIFFERENTIATED THYROID CARCINOMA:
#
Drug
Count
0
Kinase Inhibitor [EPC]
7
1
Folate Analog Metabolic Inhibitor [EPC]
2
2
Microtubule Inhibitor [EPC]
2
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
2
4
RANK Ligand Inhibitor [EPC]
2
5
GLP-1 Receptor Agonist [EPC]
1
6
Proton Pump Inhibitor [EPC]
1
7
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1